Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Prevalensi Diabetes Melitus (DM) tipe 2 cenderung meningkat di seluruh dunia dan keteraturan pengobatan masih menjadi masalah hingga saat ini. Penelitian terdahulu menemukan bahwa terdapat hubungan antara temperamen dengan kontrol glukosa namun belum banyak penelitian yang membahas hal ini. Penelitian ini bertujuan mengetahui hubungan antara temperamen dengan terkontrol atau tidak terkontrolnya DM tipe 2.Metode: Penelitian ini adalah penelitian analitik potong lintang. Pengambilan sampel dilakukan dengan consecutive sampling pada 110 penyandang DM tipe 2 di Poliklinik Metabolik Endokrin RSCM selama bulan Agustus-Desember 2015. Responden dikelompokkan menjadi penyandang DM terkontrol atau DM tidak terkontrol berdasarkan hasil laboratorium HbA1c terakhir. Responden mengisi kuesioner Modified-Temperament and Character Inventory versi bahasa Indonesia.Hasil: Hasil penelitian ini menunjukkan bahwa skor temperamen harm avoidance, novelty seeking, dan reward dependence tidak berhubungan bermakna dengan terkontrol atau tidak terkontrolnya DM tipe 2.Simpulan: Tidak ada hubungan bermakna antara temperamen dengan pengendalian kadar HbA1c pada penyandang DM tipe 2.

---

Background: Prevalence on type 2 Diabetes Mellitus (DM) tend to increase across the world and regulating treatment still being one of the matters to be discussed until recently. Previous research had found that there are correlations between temperament with glucose control but with limited study on that area. This research aim to qualify the relationship between temperament to controllable or uncontrollable type 2 DM.

Method: This research is a cross sectional sampling method. Sampling conducted with consecutive sampling on 110 respondents with type 2 DM in RSCM Metabolism Endocrine Polyclinic, sampling was done between August to December 2015. Respondents are grouped to two different groups which is controllable DM and uncontrollable DM based on last HbA1c laboratory results. Respondents were requested to fill up Modified-Temperament and Character Inventory questionnaire in Bahasa Indonesia.

Results: Result on this research indicates that temperament score in harm avoidance, novelty seeking, and reward dependence are unrelated with whether Type 2 DM being controllable or uncontrollable.

Conclusion: Absent of significant relation between temperament and HbA1c level control in type 2 DM patients."

"ABSTRAKLatar belakang : Penyakit jantung koroner (PJK) dan stroke merupakan penyebabkematian utama baik di negara Barat maupun di Indonesia terutama di daerahperkotaan. Setiap tahun lebih banyak orang meninggal karena penyakitkardiovaskular dibandingkan penyakit lain. Diabetes melitus merupakan faktorrisiko independen untuk penyakit kardiovaskular. Gangguan aliran darah yangmengakibatkan PJK maupun stroke disebabkan oleh trombosis arteri. Aktivasitrombosit diduga terjadi pada pasien diabetes melitus. Ketika trombosit teraktivasiakanterjadi beberapa perubahan diantaranya pelepasan kandungan granula danpembentukan tromboksan A2. Pengukuran tromboksan A2 sulit dilakukan karenasifatnya yang tidak stabil, maka dilakukan pengukuran terhadap metabolitnya 11-dehidro tromboksan B2. tujuan penelitian ini adalah menukur kadar 11 dehidroTxB2 di urin pada pasien diabetes melitus sebagai suatu petanda dini aktivasitrombosit dan mengkorelasikannya dengan hemoglobin A1c (HbA1c).Metoda : Empat puluh lima pasien diabetes melitus tipe 2 dan 30 non diabetessebagai kontrol diambil pada penelitian ini. Pengukuran kadar 11 dehidro TxB2 diurin dengan tehnik competitive EIA menggunakan reagen dari Cayman Chemical.Kadar 11-dehidro tromboksan B2 urin disajikan dalam bentuk rasio dengankreatinin urin. Pengukuran HbA1c dilakukan dengan metode akfinitas boronikmenggunakan NycocardR.Hasil : Pada kelompok diabetes melitus median kadar 11 dehidro TxB2 di urin1216,56 pg/mg kreatinin (70,53 – 12167,72 pg/mg kreatinin). Terdapat perbedaanbermakna dibanding kelompok non diabetes dengan median 200,55pg/mg kreatinin(57,19-602,46 pg/mg kreatinin). Terdapat korelasi yang kuat antara kadar 11dehidro TxB2 pada kelompok diabetik dengan indeks glikemik (HbA1c).Kesimpulan : 11 dehidro TxB2 di urin dapat dipakai sebagai petanda dini aktivasitrombosit pada pasien diabetes melitus dan mempunyai korelasi yang kuat denganHbA1c.

---

ABSTRACTBackground: It is widely known that heart disease and stroke are the main cause ofdeath in Western countries. This issue found in Indosesia especially in the urbam ares.Diabetes mellitus is one of the independentbrisk faktor for cardiovaskular. Cirulatorydisorder that result in coronary heart disease and stroke is arterial thrombosis. Plateletplay an important role in the pathogenesis of arterial thrombosis. Some report statedthat platelet activation occurred in diabetes mellitus. When platelet are activated, somechange happened, i.e : released of granule content and thromboxane A2 (TxA2)formation. Measurement of TxA2 as a marker for platelet activation was hampered bythe instability of this substance. Therefore it is preferred to measure their stablemetabolite 11-dehydro thromboxane B2 in urine. The aim of this study is to measureurine 11-dehydro thromboxane B2 in diabetes mellitus as an early of platelet activationand to correlate this value with hemoglobin A1c.Methode: Forty five patients with type 2 diabetes mellitus and 30 non diabetic ascontrol group were enrolled in this study. Measurement of urine 11 dehidro TxB2 wasdone by competitive EIA using reagent from Cayman Chemical. The level of urine 11-dehydro TxB2 was expressed as ratio with urine creatinine. Measurement of HbA1cwas performed by boronic affinity method using NycocardR.Result : In diabetics group the median rate for urine 11 dehydro TxB2 was 1216,56pg/mg creatinine ( 70,53 - 12167,72 pg/mg creatinine). It was significantly higher thanthat of non diabetic group, which median was 200,55 pg/mg creatinine ( 57,19 -602,46 pg/ mg creatinine). the level of urine 11-dehydro TxB2 in diabetics groupshowed a strong correlation with HbA1c as glycemic index.Conclusion: Urine 11-dehydro TxB2 can be used as an early marker of plateletactivation in diabetes mellitus patients and there was a strong correlation with HbA1c."

"[ABSTRAKDepresi banyak ditemui pada orang dengan penyakit kronis, antara lain diabetes mellitus tipe 2. Salah satu penelitian menemukan bahwa sekitar 45% dari seluruh menderita diabetes mellitus tipe 2 yang mengalami gangguan depresi namun tidak menjadi perhatian. Pasien diabetes mellitus tipe 2 yang depresi mengalami dampak yang cukup besar terhadap kualitas hidup. Penelitian ini merupakan penelitian analitik kuantitatif potong lintang (cross sectional) untuk mengetahui adanya hubungan antara gangguan depresi dengan kualitas hidup pasien diabetes mellitus tipe 2 di Poliklinik Endokrin RSCM. Hasil dari penelitian ini menyatakan kualitas hidup pasien diabetes mellitus tipe 2 yang mengalami gangguan depresi secara keseluruhan lebih buruk dibandingkan yang tidak mengalami gangguan depresi. Pasien diabetes mellitus tipe 2 yang mengalami gangguan depresi memiliki dampak yang cukup besar terhadap kualitas mereka.

---

ABSTRACTDepression is commonly found in people with chronic diseases, such as diabetes mellitus type 2. One study found that approximately 45% of all diabetes mellitus type 2 who suffered from depression but was not a concern. Type 2 diabetes mellitus patients with depression experience a considerable impact on quality of life. The methodology of this study is a cross-sectional quantitative analytic to investigate the relationship between depression and quality of life of patients with diabetes mellitus type 2 in the Endocrine Clinic RSCM. The results of this study states the quality of life of patients with type 2 diabetes mellitus who have depressive disorders are generally worse than that is not experiencing depression. Patients with type 2 diabetes mellitus who experience depression have a considerable impact on their quality of life.;Depression is commonly found in people with chronic diseases, such as diabetes mellitus type 2. One study found that approximately 45% of all diabetes mellitus type 2 who suffered from depression but was not a concern. Type 2 diabetes mellitus patients with depression experience a considerable impact on quality of life. The methodology of this study is a cross-sectional quantitative analytic to investigate the relationship between depression and quality of life of patients with diabetes mellitus type 2 in the Endocrine Clinic RSCM. The results of this study states the quality of life of patients with type 2 diabetes mellitus who have depressive disorders are generally worse than that is not experiencing depression. Patients with type 2 diabetes mellitus who experience depression have a considerable impact on their quality of life., Depression is commonly found in people with chronic diseases, such as diabetes mellitus type 2. One study found that approximately 45% of all diabetes mellitus type 2 who suffered from depression but was not a concern. Type 2 diabetes mellitus patients with depression experience a considerable impact on quality of life. The methodology of this study is a cross-sectional quantitative analytic to investigate the relationship between depression and quality of life of patients with diabetes mellitus type 2 in the Endocrine Clinic RSCM. The results of this study states the quality of life of patients with type 2 diabetes mellitus who have depressive disorders are generally worse than that is not experiencing depression. Patients with type 2 diabetes mellitus who experience depression have a considerable impact on their quality of life.]"

"Diabetes Melitus tipe 2 merupakan penyebab kematian ke-2 pada kelompok usia 45-54 tahun di daerah perkotaan, sedangkan di pedesaan menduduki peringkat ke-6. Angka kejadiannya berhubungan dengan adanya resistensi insulin akibat berbagai macam faktor. Pola paling umum dijumpai adalah dislipidemia terutama hipertrigliseridemia dan pengurangan kadar HDL. Penelitian ini dirancang untuk melihat gambaran kadar trigliserida pada pasien DM tipe 2 yang berobat ke Poli IPD RSCM pada tahun 2010. Didapatkan bahwa dari 108 subyek, 55 orang berusia ≥55 tahun, 68 orang berjenis kelamin perempuan, 71 orang tidak merokok, dan 84 orang dengan kadar trigliserida normal. Dari hasil analisis didapat hubungan tidak bermakna antara kadar trigliserida dengan usia (Mann-Whitney, p = 0.104), jenis kelamin (Chi-square, p = 0.062), perilaku merokok (Chi-square, p = 0,973), kadar gula darah puasa (Mann-Whitney, p = 0.973), dan kadar gula darah dua jam post prandial. (Mann-Whitney, p = 0.539). Rerata TG berdasarkan analisis data adalah 140,5 (49-1144) mg/dL. Nilai rerata kadar glukosa darah puasa (GDP) 186,5 (114-559) mg/dL. Analisis data menunjukkan sebaran tidak normal dengan rerata kadar gula darah dua jam post prandial (GD2PP) sebesar 291 (178-582) mg/dL.

---

Type 2 diabetic melitus is the second death cause on urban residencies age ranged 45-54 year old, while it is the 6th leading death cause on rural area, based on RISKEDA 2007. High rate of prevalencies is because insulin resistancies as results of multifactorial. Most common patern is dislipidemia especially hypertriglyceride and low level of HDL. This researh is designed to picture triglyceride level on type 2 diabetic melitus patients in RSCM on year 2010. Known that from 108 subjects, 55 are aged ≥55 year old, 68 are women, 71 don’t smoke and 84 with normal level of triglyceride. From analitic processes, known that triglyceride level is not associated with age (Mann-hitney, p = 0.104), sex (Chi-square, p = 0.062), smoking habbit (Chi-square, p = 0,973), fasting blood glucose (Mann-Whitney, p = 0.973), and 2 hours post-prandial blood glucose (Mann-Whitney, p = 0.539). Mean rate of triglyceride level is 140,5 (49-1144) mg/dL. Mean rate fasting blood glucose is 186,5 (114-559) mg/dL. Data analysis doesn’t show normal distribution on mean rate of level 2 hours post prandial blood glucose 291 (178-582) mg/dL."

"Hingga saat ini, belum ada penanda biologis yang menggambarkan kondisi penyakit ginjal kronik (PGK) akibat diabetes melitus (DM) sejak dini. Studi ini bertujuan untuk mengetahui hubungan antara rasio albumin kreatinin urin (Urine Albumin Creatinine Ratio, UACR) dengan laju filtrasi glomerulus yang diestimasi (estimated Glomerular Filtration Rate, eGFR) sebagai penanda gangguan fungsi ginjal pada pasien DM tipe 2 RSUPN Dr. Cipto Mangunkusumo. Sampel urin dan serum diambil dari 18 subjek sehat dan 10 pasien DM tipe 2. Metode spektrofotometri digunakan untuk mengukur kadar albumin urin, kreatinin urin dan kreatinin serum. Data lain diperoleh dari kuesioner. Hasilnya, nilai eGFR pasien DM (68,85 ± 15,36 (Cockroft); 73,94 ± 16,30 (CKD-EPI)) lebih rendah dibandingkan dengan subjek sehat (90,51 ± 15,69, p < 0,01 (Cockcroft); 91,13 ± 21,21, p < 0,05 (CKD-EPI)), sedangkan nilai UACR pasien DM (314,99 ± 494,92) lebih tinggi dibandingkan dengan subjek sehat (0,48 ± 0,75, p < 0,01). Namun, tidak ditemukan hubungan yang bermakna antara UACR dengan eGFR pasien DM.

---

Until now, no biological marker that describes the condition of chronic kidney disease (CKD) due to diabetes mellitus (DM) from the outset. This study aimed to determine the relationship between urine albumin creatinine ratio (UACR) with estimated Glomerular Filtration Rate (eGFR) as a marker of renal dysfunction at type 2 diabetes mellitus patients at RSUPN Dr. Cipto Mangunkusumo. Urine and serum samples taken from 18 healthy subjects and 10 type 2 diabetic patients. Spectrophotometric methods used to measure levels of urinary albumin, urinary creatinine and serum creatinine. Other data obtained from questionnaires.

Results, eGFR values were lower in DM patients (68.85 ± 15.36 (Cockroft); 73.94 ± 16.30 (CKD-EPI)) compared with healthy subjects (90.51 ± 15.69, p < 0.01 (Cockcroft); 91,13 ± 21,21, p < 0,05 (CKD-EPI)), while the value of UACR in DM patients (314.99 ± 494.92) was higher than healthy subjects (0.48 ± 0.75, p < 0.01). However, there was no significant correlation between UACR with eGFR of DM patients."

"Diabetes Melitus tipe 2 merupakan sekumpulan gangguan metabolik dengan karakteristik hiperglikemia. Komplikasi klinis akibat DM berkolerasi dengan status glikemik, sehingga diperlukan upaya pengontrolan status glikemik pasien DM, baik jangka pendek, jangka menengah maupun jangka panjang untuk mencegah atau mengurangi komplikasi progresif akibat penyakit tersebut. Parameter laboratorium untuk pemantauan status glikemik meliputi kadar glukosa darah harian, HbA1c, dan albumin glikat (AG). Penelitian ini bertujuan untuk mendapatkan gambaran kadar HbA1c dan kadar AG pada pasien DM tipe 2 tidak terkontrol, mendapatkan korelasi antara kadar HbA1c dan kadar AG, juga melihat penurunan kadar HbA1c dan AG sesudah terapi 1 dan 3 bulan. Penelitian dilakukan dengan desain studi diagnostik, yang melibatkan 32 subyek penelitian yang diikuti selama 3 bulan mulai bulan Februari hingga Mei 2014. Diagnosis DM tipe 2 ditegakkan oleh dokter Spesialis Penyakit Dalam dan diagnosis DM tipe 2 tidak terkontrol didapatkan dari hasil pemeriksaan HbA1c > 7 %. Hasil penelitian mendapatkan rerata (SD) kadar glukosa darah puasa bulan ke-0, ke-1, dan ke-3 berturut-turut sebesar 170,5(51,6) mg/dL; 162,7(54,6) mg/dL, dan 147,3(45,9) mg/dL. Median (rentang) kadar glukosa darah 2 jam postprandial l(G2PP) bulan ke-0 dan ke-1 sebesar 220 mg/dL (90-544) mg/dL dan 191,5 mg/dL (114-468) mg/dL; rerata(SD) kadar G2PP bulan ke-3 sebesar 201(65,98) mg/dL. Korelasi antara kadar HbA1c dan kadar AG adalah : pada bulan ke-0, r=0,79, p<0,001, bulan ke-1 r=0,74, p<0,001 dan bulan ke-3 r=0,78, p<0,001. Penurunan kadar HbA1c dari baseline (delta-1) dan pada bulan ke-3 (delta-3) adalah median (rentang) delta-1 sebesar 0,43% (0,35-0,74)%, p<0,001 dan median (rentang) delta-3 sebesar 0,89% (0,64-2,30)%, p<0,001. Penurunan kadar AG bulan ke-1 dari baseline (delta-1) dan pada bulan ke-3 (delta-3): median (rentang) delta-1 sebesar 0,94% (0,48-1,64)%, p<0,001, dan median (rentang) delta-3 sebesar 1,79% (0,33-1,40)%, p<0,001. Kami menyimpulkan bahwa terdapat korelasi positif bermakna antara kadar HbA1c dan kadar AG pada bulan ke-0, ke-1, dan ke-3, dengan kekuatan korelasi kuat (r = 0.7-0.8), selain itu terdapat penurunan kadar HbA1c dan AG yang bermakna sesudah terapi 1 dan 3 bulan.

---

Type 2 diabetes mellitus (T2DM) is a group of metabolic disorders with hyperglycemic characteristic. Clinical complications of DM correlate with glycemic state, therefore it is necessary to make an effort to control DM glycemic state, in short-, medium-, and long-term to prevent or minimize progressive complications due to the disease. Laboratory parameters to monitor glycemic state include daily blood glucose, HbA1c, and glycated albumin (GA).

This study aimed to obtain HbA1c and GA levels in uncontrolled type 2 DM patients, the correlations between HbA1c and GA levels, and also the decrease in HbA1c and GA levels after 1 month and 3 months treatment. This was a diagnostic study involving 32 subjects that were followed for 3 months from February to May 2014. Type 2 DM was diagnosed by the internist in the Department of Internal Medicine and the uncontrolled type 2 DM was confirmed by HbA1c measurement of > 7%.

The results showed that mean (SD) fasting blood glucose levels at baseline, 1 month and 3 months were 170.5 (51.6) mg/dL; 162.7 (54.6) mg/dL, and 147.3(45.9) mg/dL, respectively. Median (range) 2 hours postprandial blood glucose levels at baseline and 1 month respectively, were 220 mg/dL (90-544) mg/dL and 191.5 mg/dL, respectively, and mean (SD) at 3 months was 201,7 (65,98) mg/dL. Correlations between HbA1c and GA levels : at baseline r =0.79, p<0.001, at 1 month r=0.74, p<0.001 and at 3 months r=0.78, p<0.001.

Decreases of HbA1c level from baseline, at 1 month (delta-1) and at 3 months (delta-3) : median (range) delta-1was 0.43% (0.35-0.74)%, p<0.001 and median (range) delta-3 was 0.89% (0.64-2.30)%, p<0.001. Decreases of GA level from baseline, at 1 month (delta-1) and at 3 months (delta-3) : median (range) delta-1 was 0.94%(0.48-1.64)%, p<0.001, and median (range) delta-3 was 1.79%(0.33-1.40)%, p<0.001.

We concluded that there were significant positive correlations between HbA1c and GA levels at baseline,1 month and 3 months, with strong correlations (r=0.7-0.8). In addition, there were also significant decreases in HbA1c and GA levels from baseline at 1 month and 3 months therapy."

"Diabetes melitus merupakan suatu kelompok penyakit metabolik dengan hiperglikemia sebagai karakteristik utama. Hiperglikemia terjadi karena kelainan sekresi insulin, kerja insulin, dan atau keduanya. Sekitar 50% penyandang diabetes di Indonesia belum terdiagnosis sehingga komplikasi akibat DM tidak dapat dihindari. Pengendalian terjadinya komplikasi dilakukan dengan kontrol glikemik secara teratur. Pemeriksaan kontrol glikemik antara lain dengan glukosa darah puasa, HbA1c, dan fruktosamin. Penelitian ini bertujuan untuk melihat gambaran kadar fruktosamin dan HbA1c pada diabetes melitus tipe 2 tidak terkontrol, mengetahui perubahan kadar fruktosamin dan HbA1c setelah terapi 2 minggu dan 8 minggu, serta hubungan antara keduanya. Penelitian ini menggunakan desain kohort prospektif pada 33 subyek yang terdiri dari 24 orang perempuan dan 9 orang laki-laki. Subyek penelitian diikuti selama 2 minggu dan 8 minggu sejak dilakukan perubahan terapi. Penelitian dimulai pada bulan Februari sampai April 2015. Subyek yang termasuk dalam penelitian adalah diabetes mellitus tipe 2 yang tidak terkontrol dengan HbA1c>7%. Hasil penelitian diperoleh nilai median dan rentang fruktosamin pada minggu ke-0, minggu ke-2, dan minggu ke-8 berturut-turut 362 μmol/L (257-711), 327 μmol/L (234-616), dan 350 μmol/L (245-660). Kadar HbA1c memiliki nilai median dan rentang pada minggu ke-0, minggu ke-2, dan minggu ke-8 yaitu 9.3% (7.1-14.8), 8.8% (6.9-12.7), dan 8.4% (5.9-14.2). Terdapat penurunan bermakna kadar fruktosamin dan HbA1c dengan p<0.001. Adanya korelasi yang kuat dan arah korelasi yang positif antara fruktosamin dan HbA1c (minggu ke-0, r=0.86; minggu ke-2, r=0.82; minggu ke-8, r= 0.84). Pada penelitian ini diperoleh penurunan yang bermakna kadar fruktosamin dan HbA1c pada 2 minggu dan 8 minggu setelah terapi dengan korelasi yang kuat ( r > 0.8) dan arah korelasi positif. Fruktosamin lebih baik digunakan untuk kontrol glikemik jangka menengah (2 minggu) sedangkan HbA1c lebih baik dipakai untuk kontrol glikemik jangka panjang (8 minggu).

---

Diabetes mellitus is a group of metabolic diseases with hyperglycemia as the main characteristics. Hyperglycemia occurs due to abnormalities in insulin secretion, insulin action, or both. Approximately 50% of people with diabetes in Indonesia have not been diagnosed, thus complications due to diabetes cannot be avoided. Taking control of diabetes mellitus can be done through glycemic control measurements on a regular basis. Fasting blood glucose, HbA1c, and fructosamine tests are lists of key features for glycemic control measurements.

The aims of this study was to overview the levels of fructosamine and HbA1c in uncontrolled type-2 diabetes mellitus, determine changes in fructosamine and HbA1c levels after two weeks and eight weeks of treatment, and analyze the relationship between the two.

This study used a prospective cohort design with 33 subjects consisted of 24 women and 9 men. Subjects were followed for two weeks and eight weeks after the initial therapy amendment. The study began in February and April 2015. The subjects included in the study were uncontrolled type-2 diabetes mellitus with HbA1c> 7%.

Fructosamine concentration, given as median and range values, at weeks 0, 2, and 8 were 362 μmol/L (257-711), 347 μmol/L (234-660), and 333 μmol/L (235-676), respectively. HbA1c levels (median and range) at weeks 0, 2, and 8 were 9.3% (7.1-14.8), 8.8% (6.9-12.7) and 8.4% (5.9-14.2). There was a significant reduction of fructosamine and HbA1c levels (p <0.001). A strong and positive correlation were found between fructosamine and HbA1c (week 0, r = 0.86; week 2, r = 0.82; week 8, r = 0.84).

From this study, it can be concluded that fructosamine and HbA1c levels were significantly reduced at weeks 2 and 8 after treatment, with a positive strong correlation (r> 0.8). Thus, fructosamine is preferable for medium-term (two weeks) glycemic control while the HbA1c is preferred for long-term (eight weeks) glycemic control."

"Penderita Diabetes Melitus (DM) Tipe 2 mengalami peningkatan risiko kanker yang diduga diakibatkan oleh kondisi hiperglikemia, hiperinsulinemia, dan inflamasi. Ketiga faktor tersebut dapat menginduksi proses tumorigenesis melalui jalur glukotoksisitas, lipotoksisitas, dan stres oksidatif. Penelitian ini bertujuan untuk mengukur dan membandingkan mutan p53 sebagai tumor marker pada pasien DM tipe 2 dan pasien DM tipe 2 yang menderita kanker, mengukur dan membandingkan HbA1c pada kedua kelompok, serta melihat korelasi mutan p53 dengan HbA1c pada kedua kelompok. Desain studi yang digunakan adalah cross-sectional dengan teknik pengambilan sampel consecutive sampling. Kelompok yang diteliti pada penelitian ini adalah pasien DM tipe 2 (n = 51) dan pasien DM tipe 2 yang menderita kanker (n = 51). Analisis mutan p53 pada serum sampel dilakukan menggunakan ELISA, sedangkan pengukuran HbA1c dilakukan dengan Afinion Analyzer. Pada penelitian ini kadar serum mutan p53 pada kelompok pasien DM tipe 2 (1,62 ± 0,08 ng/ml) tidak berbeda bermakna dengan kelompok pasien DM tipe 2 yang menderita kanker (1,64 ± 0,09 ng/ml) (p = 0,774). Sementara itu, HbA1c pada kelompok DM tipe 2 (8,42 ± 0,25 %) berbeda bermakna dengan kelompok DM tipe 2 yang menderita kanker (7,02 ± 0,20 %) (p < 0,001). Tidak terdapat hubungan yang bermakna antara kadar mutan p53 dengan HbA1c, baik pada kelompok DM tipe 2 (r = 0,083; p = 0,561), maupun kelompok DM tipe 2 yang menderita kanker (r = 0,072; p = 0,617). Penelitian ini menunjukkan bahwa kadar mutan p53 pada kelompok DM tipe 2 dan DM tipe 2 yang menderita kanker tidak berbeda bermakna, namun HbA1c pada kedua kelompok berbeda bermakna. Sementara itu, tidak terdapat hubungan yang bermakna antara kadar mutan p53 dengan HbA1c pada kedua kelompok.

---

Type 2 Diabetes Mellitus has been found to increase the risk of cancer which is caused by conditions of hyperglycemia, hyperinsulinemia, and inflammation. These three factors are able to induce tumorigenesis through mechanisms of glucotoxicity, lipotoxicity, and oxidative stress. This study aimed to measure and compare mutant p53 as tumor marker in Type 2 Diabetes Mellitus patients and Type 2 Diabetes Mellitus patients with cancer, to measure and compare HbA1c level in both groups, and to analyze the correlation between mutant p53 and HbA1c level in both groups. This study was a cross-sectional study with consecutive sampling technique in which two groups were involved, namely type 2 diabetes mellitus patients (n = 51) and type 2 diabetes mellitus patients with cancer (n = 51). Serological level of mutant p53 protein was analyzed using ELISA and HbA1c was measured with HbA1c Afinion Analyzer.

The serological level of mutant p53 in the type 2 diabetes mellitus patients (1.62 ± 0.08 ng/ml) showed no significant difference compared with type 2 diabetes mellitus patients with cancer (1.64 ± 0.09 ng/ml) (p = 0.774). Meanwhile, HbA1c level showed significant difference between type 2 diabetes mellitus patients (8.42 ± 0.25 %) and type 2 diabetes mellitus patients with cancer (7.02 ± 0.20 %) (p < 0.001). Mild correlations between mutant p53 and HbA1c level were found in both type 2 diabetes mellitus patients (r = 0.083; p = 0.561) and type 2 diabetes mellitus patients with cancer (r = 0.072; p = 0.617). Based on the result, there was no significant difference between mutant p53 in type 2 diabetes mellitus patients with and without cancer. HbA1c level was found to be significantly different in both groups. Meanwhile, there was no significant correlation between mutant p53 and HbA1c in both groups."

"[ABSTRAKLatar belakang: mengetahui hubungan antara asupan makronutrien dan gayahidup terhadap status HbA1c penyandang diabetes melitus (DM) tipe 2. Metode:penyandang DM tipe 2 dikategorikan ke dalam 2 kelompok, yaitu kontrolglikemik (KG) baik (HbA1c < 7,0) dan KG buruk (HbA1c > 7,0). Datakarakteristik dasar seperti usia, jenis kelamin, status gizi, durasi menderita DM,jenis dan jumlah obat DM yang digunakan, serta ada/ tidaknya komplikasi DMyang diderita. Asupan makronutrien terdiri dari asupan energi total harian, asupankarbohidrat, protein, lemak dan serat. Faktor gaya hidup meliputi ketaatanmengikuti diet sesuai yang direkomendasikan, aktivitas fisik, ketaatan konsumsiobat, merokok dan minum alkohol. Data-data dari kedua kelompok kemudiandihubungkan dengan status HbA1c dengan uji Chi square. Hasil penelitian: usiapenyandang DM yang lebih muda (< 55 tahun), asupan karbohidrat dan ketaatanmengikuti diet berhubungan bermakna secara statistik dengan status HbA1c (P <0,05). Rasio asupan makronutrien (karbohidrat, protein, lemak) pada kelompokKG baik adalah 47: 18: 35 dan KG buruk 51: 16: 33. Kesimpulan : Hasilpenelitian ini menunjukkan bahwa status HbA1c berhubungan bermakna denganfaktor usia, asupan karbohidrat, dan ketaatan mengikuti diet. Edukasi sebaiknyadiberikan kepada penyandang DM tipe 2 dengan KG buruk, terutama yang berusia< 55 tahun agar mengatur pola makannya sesuai dengan yang direkomendasikandengan memperhatikan jenis, jumlah, dan jadwal.

---

ABSTRACTBackground: Determining the relationship between macronutrients intake and lifestylefactors and HbA1c status of diabetic type 2 patient in improving the effectiveness ofpatient?s nutrition therapy and preventing diabetes complications. Methods: Diabetictype 2 patients were categorized into 2 groups; patients with good glycemic control (GC)or HbA1c < 7.0 and patients with poor glycemic control (PC) or HbA1c > 7.0. Clinicalcharacteristics were differentiated by age, gender, body mass index (BMI), duration ofillness, type and amount of diabetic medication, and other diabetic complication.Macronutrient intake consisted of total daily calories and carbohydrate, protein, fat andfiber intakes. Lifestyle factors consisted of the adherence to dietary advice andmedication, physical activities, smoking habit, and alcohol intake. The data were be usedto determine their relationship with HbA1c status using Chi Square test. Results:Younger diabetic type 2 patients (< 55 years old), carbohydrate intake, and adherence todietary advice were identified as statistically significant variables related to HbA1c status(P <0.05). Macronutrient intake ratio (carbohydrate : protein : fat) for GC was 47 : 18 : 35and PC was 51 : 16 : 33. Conclusions: The results demonstrate that HbA1c status indiabetic type 2 patient are related to age, carbohydrate intake and adherence to dietaryadvice. Education to be provided to younger diabetic type 2 patients (<55 years old) tomaintain good dietary pattern according to medical nutrition therapy, Background: Determining the relationship between macronutrients intake and lifestylefactors and HbA1c status of diabetic type 2 patient in improving the effectiveness ofpatient’s nutrition therapy and preventing diabetes complications. Methods: Diabetictype 2 patients were categorized into 2 groups; patients with good glycemic control (GC)or HbA1c < 7.0 and patients with poor glycemic control (PC) or HbA1c > 7.0. Clinicalcharacteristics were differentiated by age, gender, body mass index (BMI), duration ofillness, type and amount of diabetic medication, and other diabetic complication.Macronutrient intake consisted of total daily calories and carbohydrate, protein, fat andfiber intakes. Lifestyle factors consisted of the adherence to dietary advice andmedication, physical activities, smoking habit, and alcohol intake. The data were be usedto determine their relationship with HbA1c status using Chi Square test. Results:Younger diabetic type 2 patients (< 55 years old), carbohydrate intake, and adherence todietary advice were identified as statistically significant variables related to HbA1c status(P <0.05). Macronutrient intake ratio (carbohydrate : protein : fat) for GC was 47 : 18 : 35and PC was 51 : 16 : 33. Conclusions: The results demonstrate that HbA1c status indiabetic type 2 patient are related to age, carbohydrate intake and adherence to dietaryadvice. Education to be provided to younger diabetic type 2 patients (<55 years old) tomaintain good dietary pattern according to medical nutrition therapy]"

"Diabetes melitus dan gizi kurang secara terpisah dikatakan dapat meningkatkan kejadian tuberkulosis. Studi potong lintang analitik ini bertujuan untuk mengetahui adanya hubungan antara gizi kurang dengan prevalensi tuberkulosis paru (TBP) pada pasien diabetes melitus tipe 2 (DMT2). Dari keseluruhan 462 pasien DMT2, 125 pasien (27.1%) di antaranya menderita TBP. Total pasien DMT2 yang menderita gizi kurang sebesar 125 pasien (27.1%). Sementara itu, dari keseluruhan pasien DMT2 yang menderita TBP, 78 pasien (62.4%) juga menderita gizi kurang. Hasil uji chi-square menunjukkan adanya hubungan antara gizi kurang dengan prevalensi TBP yang bermakna secara statistik (p <0.000).

---

Diabetes mellitus and undernutrition separately were proved as risk factors of tuberculosis incidence. This analytical cross sectional study aimed to measure the prevalence of lung tuberculosis (TBP) among type 2 diabetes mellitus (DMT2) patients and its association with undernutrition. A total of 462 DMT2 patients were analyzed and the results showed that 125 patients (27.1%) had TBP and 125 patients (27.1%) were undernourished. Within DMT2 patients who had TBP, there were 78 undernourished patients (62.4%). We concluded there is a highly significant statistical association between undernutrition and prevalence of TBP among DMT2 patients (p <0.000)."